Compare Medtronic PLC (MDT) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

NNDM trades at $1.545, down 0.32% today, with a bearish technical signal from moving averages. The company reported 2025 revenue of $102.44M but a net loss of $293.30M, reflecting a -286.72% net margin. Cash flow remains negative at -$112.07M, though the balance sheet shows $757.96M in cash against minimal debt. Recent news highlights cost-saving initiatives and a proposed merger with Infinite Epigenetics amid shareholder disputes with Murchinson.

Outlook remains challenged by persistent losses and cash burn, but the strong cash position provides a buffer. The proposed merger introduces strategic uncertainty. Key risks include execution on profitability and shareholder alignment. Analyst sentiment is cautious given the fundamental weaknesses and ongoing corporate actions.